Skip to main content
RY $216.56 +0.73%
RY logo

RY · Royal Bank Of Canada

Track RY — free
$216.56 +1.56 (+0.73%) At close · Aug 14
Market Cap
$300.95B
Shares
1.39B
All earnings calls

Earnings call · FY2024 Q2

Royal Bank Of Canada Q2 FY2024 Earnings Call

Royal Bank Of Canada Q2 FY2024 Earnings Call

Concluded Apr 30, 2024
Apr 30, 2024 64 turns
Period
FY2024 Q2
Runtime
Sources
1 artifact

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

HSBC Canada acquisition integration 59 Canadian Banking growth 38 Capital markets performance 25 Credit quality and provisions 10 Macro environment and central bank rate cuts 8 Wealth management and asset management 8

Management tone

Confident

Net tone +62 · moderate hedging

Grounding quotes
  • “Capital markets reported record revenue of $3.2 billion as we gained market share in key areas of focus, such as advisory and origination.”
  • “We continue to estimate the transaction will generate $1.4 billion of fully synergized adjusted earnings, excluding the accretion of purchase accounting marks. However, the initial lower-than-expected margins may push out the realization of our previously stated two-year target by a couple of quarters.”
  • “Following the uncertainty of a long approval, which led to a slowdown in net new sales, the re-energized sales force is rebuilding pipelines with clients”
  • “Overall, we still see a fairly healthy Canadian consumer, but the stressed segments we have identified are influencing our decisions to increase our allowance and reserves.”

Forward guidance

3 guided metrics

Management's latest ranges and targets are included below.

Research coverage

1 live source

Switch sources without leaving this page or losing your listening position.

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Expense synergies
within the two-year timeline we provided last quarter
$740M
Fully synergized adjusted earnings, excluding the accretion of p
fully synergized
$1.4B
Stage 3 impaired PCL ratio
this year
30% – 35%

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Dividend / share
$1.03
Full-screen source Call document